Matinas BioPharma Holdings, Inc.
MTNB
$0.5571
-$0.0429-7.15%
AMEX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.28M | -5.72M | -5.82M | -5.31M | -6.06M |
| Total Depreciation and Amortization | 244.00K | 241.00K | 240.00K | 240.00K | 238.00K |
| Total Amortization of Deferred Charges | -- | -18.00K | 18.00K | 17.00K | -- |
| Total Other Non-Cash Items | 968.00K | 972.00K | 995.00K | 1.27M | 1.21M |
| Change in Net Operating Assets | -437.00K | 1.42M | -1.20M | -795.00K | 185.00K |
| Cash from Operations | -3.50M | -3.11M | -5.77M | -4.58M | -4.42M |
| Capital Expenditure | -- | -- | -- | 0.00 | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.65M | -2.94M | 2.00M | 2.96M | 1.10M |
| Cash from Investing | 9.65M | -2.94M | 2.00M | 2.96M | 1.08M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.00K | -1.00K | -1.00K | -1.00K | -1.00K |
| Issuance of Common Stock | -- | 9.19M | 54.00K | -- | -- |
| Repurchase of Common Stock | -65.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -67.00K | 9.19M | 53.00K | -1.00K | -1.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.08M | 3.15M | -3.72M | -1.62M | -3.34M |